Alterations in type i hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with sjögren's syndrome

Arthritis and Rheumatism

Volumn 63, Issue 4, 2011, Pages 1106-1115

  González, Sergio ^a   Aguilera, Sergio ^b   Alliende, Cecilia ^a   Urzúa, Ulises ^a   Quest, Andrew F G ^a   Herrera, Luisa ^a   Molina, Claudio ^c   Hermoso, Marcela ^a   Ewert, Patricia ^a   Brito, Mónica ^a   Romo, Rafael ^d   Leyton, Cecilia ^a   Pérez, Paola ^a   González, María Julieta ^a,e  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital Exequiel González Cortés   (Chile)

^c UNIVERSIDAD MAYOR   (Chile)

^d Santa Maria Clinic   (Chile)

^e UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6BETA4 INTEGRIN; BP180 PROTEIN; BULLOUS PEMPHIGOID ANTIGEN 1; CYTOKERATIN 18; GLYCOPROTEIN; IMMUNOGLOBULIN A; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ANCHORAGE; CELL DEATH; CLINICAL ARTICLE; COMPLEX FORMATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; FEMALE; GENETIC REGULATION; HEMIDESMOSOME; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SJOEGREN SYNDROME;

ADULT; AGED; AUTOANTIGENS; BASEMENT MEMBRANE; BIOPSY; CASE-CONTROL STUDIES; EPIGENOMICS; FEMALE; HEMIDESMOSOMES; HUMANS; INTEGRIN ALPHA6BETA4; KERATIN-18; LAMININ; MALE; MEMBRANE GLYCOPROTEINS; METHYLATION; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 79953715158     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30212     Document Type: Article

References (47)

1. Goicovich E, Molina C, Perez P, Aguilera S, Fernandez J, Olea N, et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum 2003;48:2573-84. (Pubitemid 37129434)
2. Kwon YJ, Perez P, Aguilera S, Molina C, Leyton L, Alliende C, et al. Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 2006;54:3465-75. (Pubitemid 44737158)
3. Laine M, Virtanen I, Salo T, Konttinen YT. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2004;50: 3968-73. (Pubitemid 39643945)
4. Velozo J, Aguilera S, Alliende C, Ewert P, Molina C, Perez P, et al. Severe alterations in expression and localisation of α6β4 integrin in salivary gland acini from patients with Sjögren syndrome. Ann Rheum Dis 2009;68:991-6.
5. Uematsu J, Nishizawa Y, Hirako Y, Kitamura K, Usukura J, Miyata T, et al. Both type-I hemidesmosomes and adherens-type junctions contribute to the cell-substratum adhesion system in myoepithelial cells. Eur J Cell Biol 2005;84:407-15. (Pubitemid 40353078)
6. Jones JC, Hopkinson SB, Goldfinger LE. Structure and assembly of hemidesmosomes. Bioessays 1998;20:488-94. (Pubitemid 28320611)
7. Perez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, et al. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005;52:2751-60. (Pubitemid 41369103)
8. Litjens SH, de Pereda JM, Sonnenberg A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol 2006;16:376-83. (Pubitemid 44062316)
9. Franzke CW, Tasanen K, Borradori L, Huotari V, Bruckner- Tuderman L. Shedding of collagen XVII/BP180: structural motifs influence cleavage from cell surface. J Biol Chem 2004;279: 24521-9. (Pubitemid 38725318)
10. Odanagi M, Kikuchi Y, Yamazaki T, Kaneko T, Nakano H, Tamai K, et al. Transcriptional regulation of the 230-kDa bullous pemphigoid antigen gene expression by interferon regulatory factor 1 and interferon regulatory factor 2 in normal human epidermal keratinocytes. Exp Dermatol 2004;13:773-9. (Pubitemid 39625224)
11. Tamai K, Sawamura D, Do HC, Tamai Y, Li K, Uitto J. The human 230-kD bullous pemphigoid antigen gene (BPAG1): exonintron organization and identification of regulatory tissue specific elements in the promoter region. J Clin Invest 1993;92:814-22. (Pubitemid 23262403)
12. Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 2009;153:4-10.
13. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007;3:521-7. (Pubitemid 47351397)
14. Trenkmann M, Brock M, Ospelt C, Gay S. Epigenetics in rheumatoid arthritis. Clin Rev Allergy Immunol 2010;39:10-9.
15. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M, et al. Hypermethylated promoter region of DR-3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 2006;54:779-87.
16. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, Illei GG, et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010;16:34-8.
17. Ewert P, Aguilera S, Alliende C, Kwon YJ, Albornoz A, Molina C, et al. Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum 2010;62:1280-9.
18. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
19. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjö- gren's disease. J Clin Pathol 1968;21:656-60.
20. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-56. (Pubitemid 14191019)
21. Li LC. Designing PCR primer for DNA methylation mapping. Methods Mol Biol 2007;402:371-84.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
24. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994;152:5532-9. (Pubitemid 24153003)
25. Kaneko T, Tamai K, Matsuzaki Y, Yamazaki T, Nakano H, Kon A, et al. Interferon-γ down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS. Exp Dermatol 2006;15:308-14. (Pubitemid 43349072)
26. Tuller T, Kupiec M, Ruppin E. Determinants of protein abundance and translation efficiency in S. cerevisiae. PLoS Comput Biol 2007;3:e248.
27. Vogel C, de Sousa Abreu R, Ko D, Le SY, Shapiro BA, Burns SC, et al. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol 2010;6:400.
28. Molina C, Alliende C, Aguilera S, Kwon YJ, Leyton L, Martinez B, et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjögren's syndrome: association with mononuclear cell infiltration. Ann Rheum Dis 2006;65:178-83. (Pubitemid 43131990)
29. Claudepierre T, Manglapus MK, Marengi N, Radner S, Champliaud MF, Tasanen K, et al. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J Comp Neurol 2005;487:190-203. (Pubitemid 40734119)
30. Rodriguez-Jimenez FJ, Caldes T, Iniesta P, Vidart JA, Garcia- Asenjo JL, Benito M. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma. Oncol Rep 2007;17:1301-7.
31. Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y, et al. DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006;6:99-106. (Pubitemid 44630739)
32. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003;4:235-40. (Pubitemid 36322132)
33. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005;174:6212-9. (Pubitemid 40663812)
34. Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60:3613-22.
35. Ospelt C, Gay S. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol 2008;22:239-52. (Pubitemid 351606943)
36. Perez P, Anaya JM, Aguilera S, Urzua U, Munroe D, Molina C, et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun 2009;33:99-108.
37. Lu Q, Renaudineau Y, Cha S, Ilei G, Brooks WH, Selmi C, et al. Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's Syndrome Symposium. Autoimmun Rev 2010;9:627-30.
38. Cobb BL, Fei Y, Jonsson R, Bolstad AI, Brun JG, Rischmueller M, et al. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1731-2.
39. Airola K, Ahonen M, Johansson N, Heikkila P, Kere J, Kahari VM, et al. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J Histochem Cytochem 1998;46:437-47. (Pubitemid 28158463)
40. Ek M, Popovic K, Harris HE, Naucler CS, Wahren-Herlenius M. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006;54:2289-94. (Pubitemid 44051086)
41. Hopkinson SB, Baker SE, Jones JC. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α6 integrin. J Cell Biol 1995;130:117-25.
42. Hopkinson SB, Findlay K, deHart GW, Jones JC. Interaction of BP180 (type XVII collagen) and α6 integrin is necessary for stabilization of hemidesmosome structure. J Invest Dermatol 1998;111:1015-22. (Pubitemid 29115168)
43. Tasanen K, Tunggal L, Chometon G, Bruckner-Tuderman L, Aumailley M. Keratinocytes from patients lacking collagen XVII display a migratory phenotype. Am J Pathol 2004;164:2027-38. (Pubitemid 38669351)
44. Franzke CW, Has C, Schulte C, Huilaja L, Tasanen K, Aumailley M, et al. C-terminal truncation impairs glycosylation of transmembrane collagen XVII and leads to intracellular accumulation. J Biol Chem 2006;281:30260-8. (Pubitemid 44537033)
45. Wilhelmsen K, Litjens SH, Sonnenberg A. Multiple functions of the integrin α6β4 in epidermal homeostasis and tumorigenesis. Mol Cell Biol 2006;26:2877-86.
46. Koster J, Geerts D, Favre B, Borradori L, Sonnenberg A. Analysis of the interactions between BP180, BP230, plectin and the integrin α6β4 important for hemidesmosome assembly. J Cell Sci 2003; 116(Pt 2):387-99. (Pubitemid 36163879)
47. Fontao L, Stutzmann J, Gendry P, Launay JF. Regulation of the type II hemidesmosomal plaque assembly in intestinal epithelial cells. Exp Cell Res 1999;250:298-312. (Pubitemid 29367442)